Literature DB >> 2006594

Injection pain, intubating conditions and cardiovascular changes following induction of anaesthesia with propofol alone or in combination with alfentanil.

L Saarnivaara1, U M Klemola.   

Abstract

In a double-blind study, propofol (P) 2-2.5 mg.kg-1 preceded by saline (Sal) or alfentanil (A) 20-30 micrograms.kg-1 was used for anaesthetic induction in 59 young patients of ASA physical class I or II, premedicated with oxycodone 0.1 mg.kg-1 and atropine 0.01 mg.kg-1 i.m. The patients were randomly allocated to one of the four groups: Group 1 Sal + P2.5, Group 2 A20 + P2.5, Group 3 A30 + P2.5 and Group 4 A30 + P2. Pain on injection of propofol occurred in 67, 36 and 7% of the patients in the Sal + P2.5, A20 + P2.5 and A30 + P2 groups, respectively, but not at all in the A30 + P2.5 group. Intubating conditions were assessed as good, moderate, poor or impossible on the basis of jaw relaxation, ease of insertion of the tube and coughing on intubation, each on a three-point scale. In impossible cases, suxamethonium was used. In the Sal + P2.5 group, the frequencies of good, moderate, poor and impossible intubating conditions were 0, 38, 8 and 54%, respectively. The corresponding figures in the A30 + P2.5 group were 43, 46, 7 and 14% (P less than 0.05 between the groups). The other groups did not differ significantly from the Sal + P2.5 group. After injection of propofol, both systolic and diastolic arterial pressures decreased significantly in all other groups, with the exception of diastolic pressure in the Sal + P2.5 group, whereas heart rate did not differ from the control level. After intubation, systolic arterial pressure increased statistically significantly in the Sal + P2.5 and A30 + P2 groups and diastolic arterial pressure in all other groups with the exception of the A30 + P2.5 group when compared with the corresponding preceding values.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2006594     DOI: 10.1111/j.1399-6576.1991.tb03235.x

Source DB:  PubMed          Journal:  Acta Anaesthesiol Scand        ISSN: 0001-5172            Impact factor:   2.105


  8 in total

1.  Comparison of intubating conditions with propofol suxamethonium versus propofol-LIDOCAINE.

Authors:  To Isesele; Fe Amadasun; Np Edomwonyi
Journal:  J West Afr Coll Surg       Date:  2012-10

Review 2.  Avoidance versus use of neuromuscular blocking agents for improving conditions during tracheal intubation or direct laryngoscopy in adults and adolescents.

Authors:  Lars H Lundstrøm; Christophe Hv Duez; Anders K Nørskov; Charlotte V Rosenstock; Jakob L Thomsen; Ann Merete Møller; Søren Strande; Jørn Wetterslev
Journal:  Cochrane Database Syst Rev       Date:  2017-05-17

3.  Tracheal intubation without neuromuscular block in children.

Authors:  Safiya I Shaikh; Vijayalaxmi P Bellagali
Journal:  Indian J Anaesth       Date:  2010-01

Review 4.  Propofol. An update of its use in anaesthesia and conscious sedation.

Authors:  H M Bryson; B R Fulton; D Faulds
Journal:  Drugs       Date:  1995-09       Impact factor: 9.546

5.  Evaluation of Intubating Conditions with Varying Doses of Propofol without Muscle Relaxants.

Authors:  Mangesh S Gore; Kalpana D Harnagale
Journal:  J Anaesthesiol Clin Pharmacol       Date:  2011-01

6.  Use of remifentanil and alfentanil in endotracheal intubation: a comparative study.

Authors:  Farnad Imani; Mahmoud-Reza Alebouyeh; Zahra Taghipour Anvari; Seyyed Hamid Reza Faiz
Journal:  Anesth Pain Med       Date:  2011-09-26

7.  Comparing the effects of three different additional doses of propofol infusion on intubation condition and hemodynamic changes during general anesthesia under elective surgery: A randomized, placebo-controlled, double blind clinical trial.

Authors:  Mohammadreza Safavi; Azim Honarmand; Golnaz Banisadr
Journal:  Adv Biomed Res       Date:  2014-05-28

8.  Tracheal intubation without muscle relaxants: a randomized study of remifentanil or alfentanil in combination with thiopental.

Authors:  Safavi Mohammadreza; Honarmand Azim
Journal:  Ann Saudi Med       Date:  2008 Mar-Apr       Impact factor: 1.526

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.